BRNS insider transactions
Barinthus Biotherapeutics plc (BRNS) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
BRNS insiders
Everyone who has filed a Form 3, 4, 5 or 144 at Barinthus Biotherapeutics plc, latest first. Follow anyone to get their next filing.
- Oxford Science Enterprises plcformer 10% owner
- Robin WrightDirector+$36.6K
- Anne M. PhillipsDirector
- Joseph ScheerenDirector+$75.3K
- Leon HooftmanChief Medical Officer, since June 2024
- Alex HammacherDirector+$10.3K
- Pierre A. MorgonDirector
- William EnrightChief Executive Officer, Director-$36.3K
- Karen A DawesDirector
- Douglas J SwirskyPrincipal Accounting Officer, since May 2026
- Gemma BrownChief Financial Officer, since September 2022
- Graham GriffithsChief Business Officer-$116K
- Geoffrey LynnChief Scientific Officer, since December 2024
- Nadege PelletierChief Scientific Officer, since January 2023
- Margaret MarshallOfficer
- Thomas George EvansOfficer
- Christopher EllisOfficer-$309K
- M&G Alternatives Investment Management Ltd10% owner
- M&g Investment Management Ltd10% owner
- Georgy EgorovOfficer
Recent Form 3, 4, and 5 filings for BRNS
- Amendment: Former 10% owner Oxford Science Enterprises Plc closing all direct ownership in the company (SEC Form 4)4/A - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- Director Scheeren Joseph returned 23,000 units of Ordinary Shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- Director Phillips Anne M. returned 3,000 units of Ordinary Shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- Director Wright Robin returned 48,256 units of Ordinary Shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- Director Morgon Pierre A. returned 10,506 units of Ordinary Shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- Director Hammacher Alex returned 3,000 units of Ordinary Shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- Chief Medical Officer Hooftman Leon was granted 361,530 units of Ordinary Shares and returned 361,530 units of Ordinary Shares to the company (SEC Form 4)4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- Chief Executive Officer Enright William returned 1,243,377 units of Ordinary Shares to the company (SEC Form 4)4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- Director Dawes Karen A returned 1,700 units of Ordinary Shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 3 filed by new insider Swirsky Douglas J3 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Director Hammacher Alex4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Director Wright Robin4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Director Morgon Pierre A.4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Director Phillips Anne M.4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Director Scheeren Joseph4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Director Dawes Karen A4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Brown Gemma4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Enright William4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Chief Business Officer Griffiths Graham4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Hooftman Leon4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- Amendment: New insider Lynn Geoffrey claimed ownership of 640,639 units of Ordinary Shares (SEC Form 3)3/A - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- New insider Lynn Geoffrey claimed ownership of 639,752 units of Ordinary Shares (SEC Form 3)3 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Hooftman Leon4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 3 filed by new insider Hooftman Leon3 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Dawes Karen A4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Scheeren Joseph4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Phillips Anne M.4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Hammacher Alex4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Morgon Pierre A.4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Wright Robin4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)